Pharmidex logo — World leading translational research, specialist in ADMET, D...

Pharmidex

World leading translational research, specialist in ADMET, DMPK, Toxicology and GLP/GCP Discovery Bioanalysis

Founded 2002 United Kingdom London, United Kingdom 34 employees Biotechnology, Health Care +1

General Information

Company Name Pharmidex
Founded Year 2002
Location United Kingdom London, United Kingdom
Employees 34
Industries Biotechnology, Health Care, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Pharmidex. To contact Pharmidex, visit pharmidex.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Pharmidex

Pharmidex is a UK-based AAALAC-accredited CRO specializing in translational research and offering a wide range of services in the biotechnology, healthcare, and pharmaceutical industries. Established in 2002, the company's services include drug metabolism and pharmacokinetics (DMPK), bioanalysis, toxicology, histology, clinical chemistry, hematology, and in vitro ADME with a focus on in silico modeling and efficacy models tailored to specific disease programs such as oncology, CNS, respiratory, stroke, autoimmune, and metabolic diseases. With a client base of over 250 global clients, including medical charities, academic groups, biotech, and pharmaceutical companies, Pharmidex has successfully completed more than 15,000 studies. In addition to its fee-for-service offerings, the company actively seeks collaboration opportunities in grant-funded projects and has participated in over 30 collaborative grant-funded projects to date with more than 167 global collaborators. An investor analysis presents an opportunity to gauge the potential of Pharmidex in the growing pharmaceutical research and development sector.

Taxonomy: Translational Research, ADMET, DMPK, Toxicology, GLP/GCP Discovery Bioanalysis, In silico Modelling, Oncology, CNS, Respiratory, Metabolic Disease Programs, Contract Research Organization (CRO), Histology, Clinical Chemistry, Bioanalysis, In Vivo Therapeutic Discovery Models

No funding data available for Pharmidex yet.

Pharmidex Alternatives & Competitors

Pharmidex vs

Preferred Research Partner for Preclinical Discovery

24 employees
Biotechnology, Life Sciences
Pharmidex vs

US-based, End-to-End Oncology Pharmacology Solutions CRO

IPO
183 employees
Biotechnology, Health Care
Pharmidex vs
Evotec
Evotec Germany

Pioneering Drug Discovery

Grant
4693 employees
Biotechnology, Health Care

FAQ About Pharmidex

World leading translational research, specialist in ADMET, DMPK, Toxicology and GLP/GCP Discovery Bioanalysis
Pharmidex was founded in 2002.
Pharmidex is headquartered in London, United Kingdom.
Pharmidex operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Translational Research, ADMET, DMPK and Toxicology.
Pharmidex has approximately 34 employees.
Top alternatives and competitors to Pharmidex include TheraIndx Lifesciences Pvt.Ltd., Champions Oncology, Inc., Evotec, Plexxikon Inc., Sundia MediTech Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pharmidex and TheraIndx Lifesciences Pvt.Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pharmidex, https://bouncewatch.com/company/pharmidex, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes